Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries-Reference-Cited by-同舟云学术

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Published:2011 Issue:4 Volume:17 Page:SR1-SR13
ISSN:1234-1010
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Orlewska Ewa¹,Ancuta Ioan²,Anic Branimir³,Codrenau Catalin⁴,Damjanov Nemanja⁵,Djukic Predrag⁶,Ionescu Ruxandra⁷,Marinchev Lubomir⁸,Nasonov Evgeny L.⁹,Peets Tonu¹⁰,Praprotnik Sonja¹¹,Rashkov Rasho⁸,Skoupa Jana¹²,Tlustochowicz Witold¹³,Tlustochowicz Malgorzata¹³,Tomsic Matija¹¹,Veldi Tiina¹⁴,Vojinovic Jelena¹⁵,Wiland Piotr¹⁶

Affiliation:

1. Center for Pharmacoeconomics, Warsaw, Poland

2. Clinical Institute Ion Catacuzino, Bucharest, Romania

3. Clinical Hospital Zagreb, Zagreb, Croatia

4. Methodical Rheumatology Center Prof. Dr. Ion Stoia, Bucharest, Romania

5. Institute of Rheumathology, Beograd, Serbia

6. Consultant for Health Economics and Management, Beograd, Serbia

7. University of Medicine, Saint Maria UMF Carol Davila Hospital, Bucharest, Romania

8. University Hospital St. Ivan Rilski, Sofia, Bulgaria

9. Rheumatology Institute of RAMS, Moscow, Russia

10. Department of Rheumatology, East Tallinn Central Hospital, Tallinn, Estonia

11. University Medical Centre, Ljubljana, Slovenia